Sign in

CIK 0001816736

  • Large accelerated filer

Disc Medicine, Inc.

Sign in to watch
Ticker
IRON
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
851612845
Phone
+1 617-674-9274
Business address
321 ARSENAL STREET, SUITE 101, WATERTOWN, MA, 02472
Former names
Gemini Therapeutics, Inc. /DE, FS Development Corp.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$11,877,065
in 6 filings, $10.0M under 10b5-1 plans

Net −$11,877,065. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 32 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-08-21 Savage William Jacob Chief Medical Officer Option exercise · Stock Option (Right to Buy) −3,000 17,326
2023-08-15 Bitterman Kevin Director Sale −72,931 $52.40 $3.8M 882,224
2023-08-15 Atlas Venture Fund X, L.P. 10% owner Sale −111,069 $52.40 $5.8M 1,951,234
2023-08-15 Atlas Venture Fund X, L.P. 10% owner Sale −72,931 $52.40 $3.8M 882,224
2023-08-15 Savage William Jacob Chief Medical Officer Sale 10b5-1 −3,708 $52.27 $194K 3,964
2023-08-15 Savage William Jacob Chief Medical Officer Sale 10b5-1 −2,125 $53.26 $113K 1,839
2023-08-15 Savage William Jacob Chief Medical Officer Sale 10b5-1 −1,839 $53.96 $99K 0
2023-08-14 Atlas Venture Fund X, L.P. 10% owner Sale −75,000 $52.00 $3.9M 2,162,303
2023-08-14 Atlas Venture Fund X, L.P. 10% owner Sale −98,000 $53.00 $5.2M 2,064,303
2023-08-14 Atlas Venture Fund X, L.P. 10% owner Sale −2,000 $54.80 $110K 2,062,303
2023-08-09 Savage William Jacob Chief Medical Officer Sale 10b5-1 −3,200 $48.90 $156K 12,741
2023-08-09 Savage William Jacob Chief Medical Officer Sale 10b5-1 −3,588 $50.22 $180K 9,153
2023-08-09 Savage William Jacob Chief Medical Officer Sale 10b5-1 −1,481 $50.91 $75K 7,672
2023-08-01 Bryce Joanne Chief Financial Officer Option exercise 10b5-1 +4,521 $1.01 $5K 5,781
2023-08-01 Bryce Joanne Chief Financial Officer Sale 10b5-1 −3,067 $49.63 $152K 2,714
2023-08-01 Bryce Joanne Chief Financial Officer Sale 10b5-1 −1,454 $50.50 $73K 1,260
2023-08-01 Bryce Joanne Chief Financial Officer Option exercise · Stock Option (Right to Buy) 10b5-1 −4,521 1,507
2023-06-30 MacDonald Brian Richard Chief Innovation Officer Sale 10b5-1 −2,923 $44.85 $131K 14,277
2023-06-30 MacDonald Brian Richard Chief Innovation Officer Sale 10b5-1 −1,401 $45.45 $64K 12,876
2023-06-30 MacDonald Brian Richard Chief Innovation Officer Sale 10b5-1 +600 $46.76 $28K 12,276

Page 29 of 32 · 639 trades